Yu WZ - Search Results

1

[Recent advances of clinical and basic studies of ocular fundus diseases in China in the last five years].

Li XX, Zhao MW, Yu WZ. Li XX, et al. Among authors: yu wz. Zhonghua Yan Ke Za Zhi. 2005 Aug;41(8):717-23. Zhonghua Yan Ke Za Zhi. 2005. PMID: 16191328 Chinese.

2

[The effects of hematopoietic stem cells on mice vascular endothelial cells of diabetic retinopathy].

Tian B, Li XX, Shen L, Zhao M, Yan Z, Dong JQ, Yu WZ. Tian B, et al. Among authors: yu wz. Zhonghua Yan Ke Za Zhi. 2006 Sep;42(9):818-24. Zhonghua Yan Ke Za Zhi. 2006. PMID: 17173744 Chinese.

3

[The experimental study of specific inhibitor-CA-074Me of Cathepsin B suppressing retinal neovascularization].

Zhou GH, Yu WZ, Li XX. Zhou GH, et al. Among authors: yu wz. Zhonghua Yan Ke Za Zhi. 2008 Mar;44(3):207-11. Zhonghua Yan Ke Za Zhi. 2008. PMID: 18785542 Chinese.

4

[Analysis of factors affecting revitrectomy in patients with proliferative diabetic retinopathy].

Du W, Chen WQ, Yu WZ, Qu JF, Shi X, Yin J, Liang JH, Zhao MW. Du W, et al. Among authors: yu wz. Zhonghua Yi Xue Za Zhi. 2022 May 17;102(18):1389-1393. doi: 10.3760/cma.j.cn112137-20210909-02055. Zhonghua Yi Xue Za Zhi. 2022. PMID: 35545585 Chinese.

5

Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.

Huang L, Xu Y, Yu W, Li Y, Chu L, Dong J, Li X. Huang L, et al. Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3193-204. doi: 10.1167/iovs.09-3779. Epub 2010 Jan 13. Invest Ophthalmol Vis Sci. 2010. PMID: 20071679

6

Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people.

Huang L, Li Y, Guo S, Sun Y, Zhang C, Bai Y, Li S, Yang F, Zhao M, Wang B, Yu W, Zhao M, Khor CC, Li X. Huang L, et al. Invest Ophthalmol Vis Sci. 2014 Apr 17;55(4):2534-8. doi: 10.1167/iovs.13-13437. Invest Ophthalmol Vis Sci. 2014. PMID: 24692129

7

The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence.

Zhang Q, Qi Y, Chen L, Shi X, Bai Y, Huang L, Yu W, Jiang Y, Zhao M, Li X. Zhang Q, et al. Br J Ophthalmol. 2016 Oct;100(10):1443-50. doi: 10.1136/bjophthalmol-2015-308199. Epub 2016 Aug 16. Br J Ophthalmol. 2016. PMID: 27531356

8

Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.

Feng J, Qian J, Jiang Y, Zhao M, Liang J, Yin H, Chen Y, Yu W, Li X. Feng J, et al. Ophthalmology. 2017 Mar;124(3):408-409. doi: 10.1016/j.ophtha.2016.10.032. Epub 2016 Nov 30. Ophthalmology. 2017. PMID: 27914833 No abstract available.

9

Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab.

Tong Q, Yin H, Zhao M, Li X, Yu W. Tong Q, et al. BMC Ophthalmol. 2018 Jun 26;18(1):150. doi: 10.1186/s12886-018-0815-1. BMC Ophthalmol. 2018. PMID: 29940900 Free PMC article.

10

A new method of extrapolating the sweep pattern visual evoked potential acuity.

Zhou P, Zhao MW, Li XX, Hu XF, Wu X, Niu LJ, Yu WZ, Xu XL. Zhou P, et al. Among authors: yu wz. Doc Ophthalmol. 2008 Sep;117(2):85-91. doi: 10.1007/s10633-007-9095-4. Epub 2007 Oct 31. Doc Ophthalmol. 2008. PMID: 17972124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters